RUNX3 functions as an oncogene in ovarian cancer

Cecilia Wei Lin Lee, Linda Shyue Huey Chuang, Shunichi Kimura, Soak Kuan Lai, Chee Wee Ong, Benedict Yan, Manuel Salto-Tellez, Mahesh Choolani, Yoshiaki Ito

Research output: Contribution to journalArticle

43 Citations (Scopus)


The Runt domain transcription factor, RUNX3, has been shown to be a tumor suppressor in a variety of cancers including gastric, colon and breast cancer. Interestingly, an oncogenic role for RUNX3 has also been suggested in basal cell carcinoma and head and neck cancer. Here, we explore the role of RUNX3 in ovarian cancer.
Original languageEnglish
Pages (from-to)410-7
Number of pages8
JournalGynecologic Oncology
Issue number2
Publication statusPublished - Aug 2011

Bibliographical note

Copyright © 2011 Elsevier Inc. All rights reserved.


  • Gene Expression Profiling
  • Ovarian Neoplasms
  • Oncogenes
  • Humans
  • Core Binding Factor Alpha 3 Subunit
  • Cell Line, Tumor
  • Female

Fingerprint Dive into the research topics of 'RUNX3 functions as an oncogene in ovarian cancer'. Together they form a unique fingerprint.

  • Cite this

    Lee, C. W. L., Chuang, L. S. H., Kimura, S., Lai, S. K., Ong, C. W., Yan, B., Salto-Tellez, M., Choolani, M., & Ito, Y. (2011). RUNX3 functions as an oncogene in ovarian cancer. Gynecologic Oncology, 122(2), 410-7.